Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Distrutti

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- MiceCristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Biochemical Pharmacology|January 16, 2026
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinomaCristina Di Giorgio, Maria Rosaria Sette, Benedetta Sensini, et al.
Journal of the American Heart Association|November 24, 2023
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver DiseaseSilvia Marchianò, Michele Biagioli, Martina Bordoni, et al.
Cells|February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric CancerCristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2024
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonismMichele Biagioli, Cristina Di Giorgio, Carmen Massa, et al.
Biochemical Pharmacology|November 5, 2023
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular diseaseMichele Biagioli, Silvia Marchianò, Cristina Di Giorgio, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2023
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancerCristina Di Giorgio, Rachele Bellini, Antonio Lupia, et al.
Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- MiceCristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Biochemical Pharmacology|January 16, 2026
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinomaCristina Di Giorgio, Maria Rosaria Sette, Benedetta Sensini, et al.
Journal of the American Heart Association|November 24, 2023
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver DiseaseSilvia Marchianò, Michele Biagioli, Martina Bordoni, et al.
Cells|February 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric CancerCristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 10, 2024
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonismMichele Biagioli, Cristina Di Giorgio, Carmen Massa, et al.
Biochemical Pharmacology|November 5, 2023
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular diseaseMichele Biagioli, Silvia Marchianò, Cristina Di Giorgio, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2023
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancerCristina Di Giorgio, Rachele Bellini, Antonio Lupia, et al.
Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Pageof 14